It sounds like you've had quite a journey with your treatments for hidradenitis suppurativa (HS). Cosentyx (Secukinumab) is another option that your doctor is considering, which is a biologic disease-modifying antirheumatic drug (DMARD). It works differently from Humira and Remicade by specifically targeting interleukin Show Full Answer

It sounds like you've had quite a journey with your treatments for hidradenitis suppurativa (HS). Cosentyx (Secukinumab) is another option that your doctor is considering, which is a biologic disease-modifying antirheumatic drug (DMARD). It works differently from Humira and Remicade by specifically targeting interleukin 17A, a key player in the inflammation process associated with HS.

Here are some key points about Cosentyx:
- **Administration**: Cosentyx is administered via subcutaneous injection every four weeks, and possibly every two weeks if the initial response isn't sufficient.
- **Common Side Effects**: These include cold symptoms, upper respiratory tract infections, and diarrhea.
- **Serious Side Effects**: Though rare, they can include severe infections, inflammatory bowel disease, and hypersensitivity reactions.

It's important to discuss the potential benefits and risks with your doctor to see if Cosentyx might be a suitable option for you given your past experiences with other treatments.

 This AI-generated response comes from myHSteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Cosentyx (Secukinumab) for Hidradenitis suppurativa | myHSteam

Is HS an Autoimmune Condition? | myHSteam